Brief: Matinas Biopharma Reports Qtrly Loss Per Share $0.03
10/05/2023 22:15
May 10 (Reuters) - Matinas BioPharma Holdings Inc
MTNB.A :
* MATINAS BIOPHARMA REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
AND PROVIDES A BUSINESS UPDATE
* MATINAS BIOPHARMA HOLDINGS INC - QTRLY LOSS PER SHARE
$0.03
* MATINAS BIOPHARMA HOLDINGS - CASH, CASH EQUIVALENTS AND
MARKETABLE SECURITIES AS OF MARCH 31, 2023 WERE $24.9 MILLION
* MATINAS BIOPHARMA HOLDINGS - BELIEVES ITS CASH POSITION IS
SUFFICIENT TO FUND PLANNED OPERATIONS INTO THE SECOND HALF OF
2024
Source text for Eikon: ID:nGNX43PhWP
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: GH Power Signs Multi-Year Hydrogen Offtake Agreement With Change Energy For Hamilton Facility Output
Brief: Gh Power And Tkms Continue To Explore Clean Energy Collaboration In Support Of Canada’S Future Patrol Submarine Project
Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
Brief: Matinas Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards And Acceptance Of Plan To Regain Compliance
Brief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing